Skip to main content

Hydralazine / isosorbide dinitrate Side Effects

Medically reviewed by Drugs.com. Last updated on Nov 19, 2023.

Applies to hydralazine / isosorbide dinitrate: oral tablet.

Serious side effects

Along with its needed effects, hydralazine/isosorbide dinitrate may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking hydralazine/isosorbide dinitrate:

More common

Less common

Incidence not known

Other side effects

Some side effects of hydralazine / isosorbide dinitrate may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Incidence not known

For Healthcare Professionals

Applies to hydralazine / isosorbide dinitrate: oral tablet.

General

The most common side effects were headache, dizziness, asthenia, and nausea.[Ref]

Nervous system

Very common (10% or more): Headache (50%), dizziness (32%)

Common (1% to 10%): Paresthesia

Postmarketing reports: Tinnitus, dysgeusia, hypoesthesia, migraine, syncope[Ref]

Other

Very common (10% or more): Asthenia (14%)

Postmarketing reports: Vertigo, facial pain, chest discomfort, chest pain, peripheral edema[Ref]

Gastrointestinal

Very common (10% or more): Nausea (10%)

Common (1% to 10%): Vomiting

Postmarketing reports: Abdominal discomfort, constipation[Ref]

Cardiovascular

Common (1% to 10%): Hypotension, ventricular tachycardia

Postmarketing reports: Palpitations, flushing[Ref]

Ocular

Common (1% to 10%): Amblyopia

Postmarketing reports: Eyelid edema, vision blurred[Ref]

Respiratory

Common (1% to 10%): Sinusitis

Postmarketing reports: Dyspnea[Ref]

Dermatologic

Postmarketing reports: Erythema, hyperhidrosis, pruritus, face swelling[Ref]

Genitourinary

Postmarketing reports: Chromaturia, erectile dysfunction[Ref]

Musculoskeletal

Postmarketing reports: Pain in extremity, myalgia[Ref]

Renal

Postmarketing reports: Pulmonary renal syndrome[Ref]

References

1. Product Information. BiDil (hydralazine-isosorbide dinitrate). NitroMed Inc. 2005.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.